Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04882501 · ClinicalTrials.gov registry record · NA

Effects of Aromatherapy on Nausea Levels

A NA study, sponsored by Inova Health Care Services.

Completed
Registry status
NA
Development phase
113
Enrollment target

NCT04882501 is a NA study that has completed, run by Inova Health Care Services. The registered enrollment target is 113 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04882501, a NA study, has completed, sponsored by Inova Health Care Services.

COMPLETED
Registry status
NA
Development phase
113 participants
Enrollment target

Study Summary

Aromatherapy is the therapeutic use of essential oils from plants for the improvement of physical, emotional, and spiritual well-being. Healthcare providers play an important role in improving the care of patients with nausea. Aromatherapy is a complementary therapy that may help with post-operative nausea in the adult post-operative bariatric patient population. The purpose of this study is to evaluate the effects of aromatherapy intervention on nausea levels with post-operative bariatric patients once they are on the surgical unit.

Interventions

  • OTHER QUEASEEase aromatherapy quick tab
  • OTHER Placebo product

Trial Details

FieldValue
Enrollment Target 113 participants
Start Date 2021-04-19
Est. Completion 2022-09-01
Phase NA

Sponsor

Inova Health Care Services

75 total trials

What the Registry Record Tells You About NCT04882501

The ClinicalTrials.gov registry entry for NCT04882501 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 113 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Inova Health Care Services, which has 75 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which QUEASEEase aromatherapy quick tab is the first listed.

NCT04882501 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04882501 about?

NCT04882501 is a clinical study titled "Effects of Aromatherapy on Nausea Levels". Aromatherapy is the therapeutic use of essential oils from plants for the improvement of physical, emotional, and spiritual well-being. Healthcare providers play an important role in improving the care of patients with nausea. Aromatherapy is a complementary therapy that may help with post-operative...

What is the current status of trial NCT04882501?

This trial is currently completed. It is a NA study. The enrollment target is 113 participants. The study started on 2021-04-19. Estimated completion is 2022-09-01.

What interventions are being tested in trial NCT04882501?

The interventions under investigation include: QUEASEEase aromatherapy quick tab (OTHER), Placebo product (OTHER).

Who is sponsoring clinical trial NCT04882501?

This trial is sponsored by Inova Health Care Services, which has 75 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.